GLENMARK UK & MERCK GENERICS TO DEVELOP AND MARKET 8 DERMATOLOGICAL PRODUCTS FOR EUROPE

Glenmark Pharmaceutical (UK) Ltd, a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) and Generics (UK) Limited, on behalf of the Merck Generics Group (Merck Generics), a subsidiary of Merck KGaA of Darmstadt, Germany, have entered into an agreement for the joint development, filing and marketing of 8 generic dermatological products for Europe, which have a current annual sales value of around USD 225 million in the region.

Pharmabiz (http://pharmabiz.com/article/detnews.asp?articleid=34265§ionid=)